Okada, M and Payne, TR and Zheng, B and Oshima, H and Momoi, N and Tobita, K and Keller, BB and Phillippi, JA and Péault, B and Huard, J
(2008)
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium.
Journal of the American College of Cardiology, 52 (23).
1869 - 1880.
ISSN 0735-1097
![[img]](http://d-scholarship.pitt.edu/style/images/fileicons/text_plain.png) |
Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)
|
Abstract
Objectives: The aim of this study was to evaluate the therapeutic potential of human skeletal muscle-derived myoendothelial cells for myocardial infarct repair. Background: We have recently identified and purified a novel population of myoendothelial cells from human skeletal muscle. These cells coexpress myogenic and endothelial cell markers and produce robust muscle regeneration when injected into cardiotoxin-injured skeletal muscle. Methods: Myoendothelial cells were isolated from biopsies of human skeletal muscle using a fluorescence-activated cell sorter along with populations of regular myoblasts and endothelial cells. Acute myocardial infarction was induced in male immune-deficient mice, and cells were directly injected into the ischemic area. Cardiac function was assessed by echocardiography, and donor cell engraftment, angiogenesis, scar tissue, endogenous cardiomyocyte proliferation, and apoptosis were all evaluated by immunohistochemistry. Results: A greater improvement in left ventricular function was observed after intramyocardial injection of myoendothelial cells when compared with that seen in hearts injected with myoblast or endothelial cells. Transplanted myoendothelial cells generated robust engraftments within the infarcted myocardium, and also stimulated angiogenesis, attenuation of scar tissue, and proliferation and survival of endogenous cardiomyocytes more effectively than transplanted myoblasts or endothelial cells. Conclusions: Our findings suggest that myoendothelial cells represent a novel cell population from human skeletal muscle that may hold promise for cardiac repair. © 2008 American College of Cardiology Foundation.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID  |
---|
Okada, M | | | | Payne, TR | | | | Zheng, B | | | | Oshima, H | | | | Momoi, N | | | | Tobita, K | kit3@pitt.edu | KIT3 | | Keller, BB | | | | Phillippi, JA | jap103@pitt.edu | JAP103 | | Péault, B | | | | Huard, J | | | |
|
Centers: |
Other Centers, Institutes, Offices, or Units > Stem Cell Research Center |
Date: |
2 December 2008 |
Date Type: |
Publication |
Journal or Publication Title: |
Journal of the American College of Cardiology |
Volume: |
52 |
Number: |
23 |
Page Range: |
1869 - 1880 |
DOI or Unique Handle: |
10.1016/j.jacc.2008.07.064 |
Schools and Programs: |
School of Medicine > Biochemistry and Molecular Genetics School of Medicine > Orthopaedic Surgery School of Medicine > Pediatrics Swanson School of Engineering > Bioengineering |
Refereed: |
Yes |
ISSN: |
0735-1097 |
MeSH Headings: |
Adult; Animals; Apoptosis; Cell Separation; Cell Transplantation--methods; Endothelial Cells--cytology; Female; Flow Cytometry; Humans; Male; Mice; Muscle, Skeletal--cytology; Muscle, Skeletal--metabolism; Muscle, Skeletal--pathology; Myoblasts--cytology; Myocardial Infarction--pathology; Myocardial Infarction--therapy; Myocardium--pathology; Vascular Endothelial Growth Factor A--metabolism |
Other ID: |
NLM NIHMS80739, NLM PMC2719893 |
PubMed Central ID: |
PMC2719893 |
PubMed ID: |
19038685 |
Date Deposited: |
15 May 2014 20:29 |
Last Modified: |
03 Feb 2019 01:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/21597 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |